GRI Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a pipeline of Natural Killer T (NKT) modulating therapies for the treatment of inflammatory, fibrotic and autoimmune diseases. The Company's lead program, GR... Read more
MarketWatch
SeekingAlpha
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.